Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2026-01-01 @ 2:59 PM
Study NCT ID:
NCT06237335
Status:
RECRUITING
Last Update Posted:
2025-11-17
First Post:
2024-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF
Sponsor:
ReCode Therapeutics
Organization: